Pharma Industry

Plasma therapy to fight the virus: throwing everything at the wall to see what sticks


A bag containing plasma extracted through a process called plasmapheresis at Hemorio in Rio de Janeiro, Brazil.


It’s a seemingly easy, affordable, and low-risk treatment being suggested for Covid-19 patients. In reality, plasma therapy remains an experimental intervention and has failed to scale up as a standard treatment. Anecdotal results have helped fuel hype about the therapy, highlighting the need for hard evidence backed by standard safety procedures.

For two momentous events separated by a century, the similarities are uncanny. The Spanish flu of 1918 and the current Covid-19 outbreak spanned continents, overwhelmed healthcare systems, and raged on for several months. Responses to both the crises were marked by confusion and misinformation. But amid all the chaos, one simple therapy offered some hope. Like they did a hundred years ago, doctors and policymakers are falling back on

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise


Source link